Patient Guide: A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 259 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05531565
Status: 🟢 Enrolling Now
Condition: Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus
Phase: PHASE2, PHASE3

Where You Can Participate

This study is available at 259 locations across the country.

Top locations include:
  • • Anniston, Alabama
  • • Birmingham, Alabama
  • • Phoenix, Arizona
  • • And 256 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus - Join Clinical Trial NCTNCT05531565

How to Join This Clinical Trial - NCTNCT05531565

Learn how to participate in this PHASE2, PHASE3 trial studying an investigational therapy for Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2, PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05531565 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 259 locations. Find a study site near you:

Clinical Research Site

Anniston, Alabama 36207 - United States

Status: RECRUITING

Clinical Research Site

Birmingham, Alabama 35233-7340 - United States

Status: RECRUITING

Clinical Research Site

Phoenix, Arizona 85032 - United States

Status: RECRUITING

Clinical Research Site

La Jolla, California 92037 - United States

Status: RECRUITING

Clinical Research Site

Los Angeles, California 90045 - United States

Status: RECRUITING

Clinical Research Site

Santa Monica, California 90404 - United States

Status: COMPLETED

Clinical Research Site

Upland, California 91786 - United States

Status: RECRUITING

Clinical Research Site

Denver, Colorado 80230 - United States

Status: COMPLETED

Clinical Research Site

DeBary, Florida 32713 - United States

Status: RECRUITING

Clinical Research Site

Fort Lauderdale, Florida 33334 - United States

Status: COMPLETED

And 249 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2, PHASE3 clinical trial for Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships